It had posted a net profit of Rs 357.68 crore in the same quarter a year ago.

The generic would be used for treatment of asthma and chronic obstructive pulmonary disease.

The agreement grants Lupin exclusive rights to promote, distribute and market InspiraChamber VHC in the US, it added.

Nifty also managed to reclaim its crucial psychological level of 8850, supported by gains in capital goods, consumer durable, FMCG and real...

Indian markets are expected to trade in a range. Here is a list of twelve stocks which are likely to be in focus today.

Lupin has set up a dedicated centre of excellence for inhalation research in Florida after having hired top notch inhalation scientists las...